What is EYPT (EYPT) stock price today?

EYPT (EYPT) is currently trading at $12.41, up 1.8% today.

What is EYPT P/E ratio?

EYPT's P/E ratio is -4.34. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is EYPT return on equity (ROE)?

EYPT's return on equity (ROE) is -75.82%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is EYPT's market cap?

EYPT has a market capitalization of $1.04B.

NGM · Biotechnology

EYPT (EYPT) Stock

$12.41 +1.80% NGM: EYPT Healthcare

Valuation

Metric	Value
Price	$12.41
Market Cap	$1.04B
P/E Ratio	-4.34
P/B Ratio	3.75
P/S Ratio	37.03
EPS (TTM)	$-3.17
52-Week High	$19.11
52-Week Low	$7.94
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	-75.82%
ROA	-63.74%
ROCE	-79.41%
Gross Margin	-787.10%
Operating Margin	-783.87%
Net Margin	-748.39%
Debt/Equity	0.07
Current Ratio	8.89

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$37.0M	$41.0M	$46.0M	$43.0M	$31.0M
Operating Profit	$-55.0M	$-100.0M	$-75.0M	$-146.0M	$-243.0M
Net Profit	$-58.0M	$-102.0M	$-71.0M	$-131.0M	$-232.0M
EPS	$-2.03	$-2.74	$-1.82	$-2.32	$-3.17
Op Margin	-149.6%	-240.7%	-163.1%	-337.1%	-776.0%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$263.0M	$180.0M	$355.0M	$418.0M	$364.0M
Total Liabilities	$79.0M	$84.0M	$89.0M	$82.0M	$58.0M
Cash	$179.0M	$96.0M	$281.0M	$100.0M	$102.0M
Borrowings	$39.0M	$46.0M	$5.0M	$22.0M	$21.0M

Latest News

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire · Jul 16, 2026 EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer GlobeNewswire · Jul 13, 2026 Here’s Why EyePoint, Inc. (EYPT) Is Among the Best Get Rich Quick Stocks Insider Monkey · Jul 7, 2026 EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears MarketBeat · May 26, 2026 How The EyePoint (EYPT) Narrative Is Evolving With DURAVYU Trials And New Analyst Targets Simply Wall St. · May 21, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-50.0M	$-65.0M	$2.0M	$-126.0M	$-240.0M
Investing Cash Flow	$-33.0M	$-19.0M	$-7.0M	$-223.0M	$65.0M
Financing Cash Flow	$0	$-3.0M	$1.0M	$1.0M	$-1.0M
Net Cash Flow	$134.0M	$-83.0M	$186.0M	$-182.0M	$2.0M
Free Cash Flow	$-50.0M	$-67.0M	$-2.0M	$-130.0M	$-243.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-21.17%
Quick Ratio	8.84
Interest Coverage	—
Return 1Y	16.54%
Return 3Y	18.99%
Return 5Y	79.95%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BCAX	$27.81	+2.92%	-7.37	$1.52B	0.00%
KOD	$41.58	-2.16%	-8.11	$2.60B	0.00%
KURA	$9.57	+3.13%	-2.90	$849.57M	0.00%
NRIX	$24.11	-0.17%	-6.41	$2.50B	0.00%
PRME	$3.01	+2.03%	-3.33	$543.66M	0.00%

About EYPT

EYPT is led by CEO Jay S. Duker, employs 165 people, headquartered in US, publicly traded since 2005.

EYPT stock trades at $12.41 with a market capitalization of $1.04B. The stock is valued at a price-to-earnings (P/E) ratio of -4.34, price-to-book of 3.75, price-to-sales of 37.03. Over the past 52 weeks the stock has ranged between $7.94 and $19.11, and currently trades 35.1% below its 52-week high.

On profitability, EYPT generates a return on equity (ROE) of -75.82%, return on capital employed of -79.41%, an operating margin of -783.87%, a net profit margin of -748.39%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides